RxDoctor Payments Data

Oswaldo Sandoval, MD

Family Medicine · Davie, FLNPI 1861435760

Payments from drug & device makers

$6,758in general payments, 2019–2025

Across 206 payments — averaging $32.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novo Nordisk$677
  • Pfizer$512
  • Cashflow Solutions, LLC$365
  • AstraZeneca$299
  • Exact Sciences$291
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$4,25491%
  • Education$351%
  • Other$3658%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,758 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$16,998
Medicare patients
50
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin31$31,428
TrulicityDulaglutide18$27,433
EliquisApixaban19$20,440
XareltoRivaroxaban12$17,973
OzempicSemaglutide19$17,552
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,343
Rosuvastatin Calcium138$1,970
Atorvastatin Calcium180$1,640
Albuterol Sulfate HfaAlbuterol Sulfate33$1,169
Levothyroxine Sodium103$994
Losartan Potassium105$863
Amlodipine Besylate146$769
Pantoprazole Sodium64$630
Metformin Hcl110$612
Lisinopril87$589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$202$31,42831 claims
Lilly USA, LLCTrulicity$291$27,43318 claims
PfizerEliquis$512$20,44019 claims
Johnson & JohnsonXarelto$83$17,97312 claims
Novo NordiskOzempic$677$17,55219 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$994103 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Davie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →